KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Opko Health (OPK) Short-term Investments (2016 - 2018)

Opko Health filings provide 5 years of Short-term Investments readings, the most recent being $26.3 million for Q4 2018.

On a quarterly basis, Short-term Investments changed N/A to $26.3 million in Q4 2018 year-over-year; TTM through Dec 2018 was $26.3 million, a N/A change, with the full-year FY2018 number at $26.3 million, changed N/A from a year prior.
Short-term Investments hit $26.3 million in Q4 2018 for Opko Health, up from $15.6 million in the prior quarter.
In the past five years, Short-term Investments ranged from a high of $26.3 million in Q4 2018 to a low of $15.6 million in Q2 2016.